Education
About Us
Working with TipRanks
Follow Us
Restart Life Sciences Corp. (TSE:HEAL)
:HEAL
HEAL Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.03 - C$0.18
Previous CloseN/A
Volume800.00
Average Volume (3M)3.45K
Market Cap
C$2.52M
Enterprise ValueC$1.92M
Total Cash (Recent Filing)C$388.31K
Total Debt (Recent Filing)C$0.00
Price to Earnings (P/E)4.0
Beta2.64
Next Earnings
Nov 26, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding36,050,354
10 Day Avg. Volume4,680
30 Day Avg. Volume3,450
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)-3.07
Price to Sales (P/S)0.00
P/FCF Ratio-12.78
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Restart Life Sciences News
HEAL FAQ
What was Restart Life Sciences Corp.’s price range in the past 12 months?
Restart Life Sciences Corp. lowest stock price was C$0.03 and its highest was C$0.17 in the past 12 months.
What is Restart Life Sciences Corp.’s market cap?
Restart Life Sciences Corp.’s market cap is C$2.52M.
When is Restart Life Sciences Corp.’s upcoming earnings report date?
Restart Life Sciences Corp.’s upcoming earnings report date is Nov 26, 2025 which is in 57 days.
How were Restart Life Sciences Corp.’s earnings last quarter?
Restart Life Sciences Corp. released its earnings results on Aug 22, 2025. The company reported -C$0.006 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.006.
Is Restart Life Sciences Corp. overvalued?
According to Wall Street analysts Restart Life Sciences Corp.’s price is currently Overvalued.
Does Restart Life Sciences Corp. pay dividends?
Restart Life Sciences Corp. does not currently pay dividends.
What is Restart Life Sciences Corp.’s EPS estimate?
Restart Life Sciences Corp.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Restart Life Sciences Corp. have?
Restart Life Sciences Corp. has 36,050,354 shares outstanding.
What happened to Restart Life Sciences Corp.’s price movement after its last earnings report?
Restart Life Sciences Corp. reported an EPS of -C$0.006 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Restart Life Sciences Corp.?
Currently, no hedge funds are holding shares in TSE:HEAL
Company Description
Restart Life Sciences Corp.
Restart Life Sciences Corp., through its subsidiaries, operates as a biotechnology company worldwide. It engages in developing natural remedies specifically tailored for individuals on the autism spectrum; health-related foods that promote both mind and body wellness for healthy living, as well as psilocybin clinical trial for fragile X syndrome. The company was formerly known as Nova Mentis Life Science Corp. and changed its name to Restart Life Sciences Corp. in November 2024. Restart Life Sciences Corp. was incorporated in 2004 and is based in Vancouver, Canada.
Technical Analysis
Options Prices
Currently, No data available
---